BioSpace News Archive

Deals

Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update

Achieve Life Sciences, Inc. provided an update on the cytisinicline clinical development program and announced first quarter 2019 financial results.

May 15, 2019
·
5 min read
Biotech Beach

HCP Named to CR Magazine’s 100 Best Corporate Citizens List for 2019

HCP, Inc. announced that it was named to Corporate Responsibility Magazine’s 100 Best Corporate Citizens List for 2019.

May 15, 2019
·
2 min read
Business

Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 Million, a 18.0% Increase from Comparable Quarter in the Prior Year

nnovus Pharmaceuticals, Inc. announced its reported results for the three months ended March 31, 2019.

May 15, 2019
·
7 min read
Deals

Sangamo Therapeutics Announces Presentations At Upcoming Scientific, Medical And Investor Conferences

Hemophilia A SB-525 gene therapy clinical data accepted for oral presentation at ISTH

May 15, 2019
·
2 min read
Pharm Country

Eagle Pharmaceuticals, Inc. to Present at 2019 RBC Capital Markets Global Healthcare Conference

Eagle Pharmaceuticals, Inc. announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 2019 RBC Capital Markets Global Healthcare Conference

May 15, 2019
·
1 min read
Tracking Symptoms: New Regenstrief and IU Tool Helps Providers Identify Underlying Causes

An easy to use, brief, inexpensive new tool developed and validated by researchers at the Regenstrief Institute and Indiana University will help healthcare providers track and potentially identify early onset of more complex, serious underlying issues that could otherwise go undetected.

May 15, 2019
·
4 min read
Pharm Country

TGaS® Launches Medical Affairs Advisory Practice, Appoints New Leader

TGaS Advisors, a division of Trinity Partners, is launching a Medical Affairs practice to provide life sciences companies with benchmarking, advisory and membership services designed to support evidence-based decision-making in this critical area. Christopher A. Welsh, PharmD, MBA, leads the new practice.

May 15, 2019
·
2 min read
ASCO selects lurbinectedin second line small cell lung cancer abstract for “Best of ASCO” program

ASCO has hand selected PharmaMar’s (MSE:PHM) abstract 8906 for the “Best of ASCO” meetings in the summer over three US cities and 30 others over 5 continents.

May 15, 2019
·
3 min read
Drug Development

Marinomed Biotech AG: Budesolv with a strongly decreased dose of the active ingredient compared to the marketed product Rhinocort Aqua shows pronounced efficacy already after first application – clinical validation of the Marinosolv® platform

The pivotal phase III study for Budesolv has provided Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, with clinical validation of the efficacy of its innovative Marinosolv® technology platform.

May 15, 2019
·
4 min read
Deals

ALPHAEON Corporation sells 4 million shares in Evolus Inc.

ALPHAEON Corporation announced that it has agreed to sell approximately 4.0 million shares of common stock in Evolus, Inc. in an underwritten public offering with Morgan Stanley acting as sole underwriter for the offering.

May 15, 2019
·
2 min read